ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 47 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,230,000 | +9361.5% | 450,673 | +12656.1% | 0.00% | – |
| Q2 2019 | $13,000 | -91.0% | 3,533 | -83.0% | 0.00% | – |
| Q1 2019 | $144,000 | -4.6% | 20,810 | -25.7% | 0.00% | – |
| Q4 2018 | $151,000 | -74.3% | 28,023 | -48.9% | 0.00% | – |
| Q3 2018 | $588,000 | -66.9% | 54,856 | -59.8% | 0.00% | -100.0% |
| Q2 2018 | $1,776,000 | +2268.0% | 136,381 | +1860.3% | 0.00% | – |
| Q1 2018 | $75,000 | -36.4% | 6,957 | -41.3% | 0.00% | – |
| Q4 2017 | $118,000 | – | 11,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |